What Happened?
, -based Elevation Oncology Appointed Eddie Kim as Director, Financial Planning and Analysis
Date of management change: May 06, 2022
, -based Elevation Oncology Appointed Eddie Kim as Director, Financial Planning and Analysis
Elevation Oncology is founded on the belief that every patient living with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. We aim to make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of tumor growth. Together with our peers, we work towards a future in which each tumor`s unique genomic test result can be matched with a purpose-built precision medicine to enable an individualized treatment plan for each patient. Our lead candidate, seribantumab, is intended to inhibit tumor growth driven by NRG1 fusions and is currently being evaluated in the Phase 2 CRESTONE study for patients with solid tumors of any origin that have an NRG1 gene fusion.
Eddie Kim is Director, Financial Planning and Analysis at Elevation Oncology. Previously, Eddie held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Kight Patricia, Menendez Jesus, Nadler Laura, Supian Andry, Young Christopher, Rundquist Heather, Blair Shannon, Tannenbaum Ginay, Kannan Krishna, Cooper James, Dewyer Laura
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.